Lab
Msu Health Lab, LLC
Msu Health Lab, LLC was paid $424K by Medicaid between Jan 2024 and Jun 2024, across 64 billing codes. Its largest line is 80307, Drug test(s), presumptive, any number of drug classes; immunoassay — 15% of everything it billed.
33Billing provider infoMSU HEALTH LAB, LLC
WATERFORD, MI 48327
WATERFORD, MI 48327
33aNPI1710656129assigned 09/09/2021
33bProvider typeClinical Medical Laboratory
28Total paid$424K
24GClaims21,893
24DCodes billed64
24AFirst – last monthJan 2024 – Jun 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Michigan
Rank by total paid#60 of 108
Median peer was paid$588K
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2024incomplete | 21,893 | $424K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 15% | 1,437 | 1,104 | $62K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 13% | 731 | 635 | $56K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 10% | 674 | 615 | $44K |
| 87481 | 7.3% | 530 | 520 | $31K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.8% | 796 | 781 | $20K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 4.8% | 793 | 779 | $20K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 3.9% | 144 | 142 | $17K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 3.6% | 1,008 | 1,002 | $15K |
| 87511 | 3.2% | 530 | 520 | $14K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 3.2% | 687 | 674 | $14K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.0% | 1,152 | 1,140 | $13K |
| 80053 | Comprehensive metabolic panel | 2.6% | 1,487 | 1,449 | $11K |
52 more codes
| 80061 | Lipid panel | 2.4% | 1,170 | $10K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.1% | 1,646 | $9K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.7% | 1,129 | $7K |
| 80074 | 1.6% | 259 | $7K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.5% | 376 | $6K |
| 36415 | Collection of venous blood by venipuncture | 1.3% | 1,136 | $6K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.3% | 141 | $5K |
| 81514 | 1.2% | 34 | $5K | |
| 87563 | 1.2% | 202 | $5K | |
| 82607 | 1.0% | 679 | $4K | |
| 82746 | <1% | 372 | $4K | |
| 84439 | <1% | 607 | $4K | |
| 87653 | <1% | 135 | $3K | |
| 84481 | <1% | 307 | $3K | |
| 82728 | <1% | 262 | $3K | |
| 84425 | <1% | 190 | $3K | |
| 83013 | <1% | 41 | $2K | |
| 87640 | <1% | 66 | $2K | |
| 86803 | <1% | 141 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 290 | $1K |
| 84403 | <1% | 83 | $1K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 69 | $1K |
| 84146 | <1% | 98 | $1K | |
| 85027 | <1% | 234 | $1K | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 87 | $1K |
| 86780 | <1% | 95 | $833.63 | |
| 83735 | <1% | 175 | $825.61 | |
| 82248 | <1% | 251 | $795.70 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 29 | $749.55 |
| 84702 | <1% | 87 | $725.73 | |
| 87340 | <1% | 93 | $707.05 | |
| 84480 | <1% | 61 | $651.38 | |
| 83540 | <1% | 137 | $630.57 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 93 | $571.36 |
| 82043 | <1% | 132 | $530.58 | |
| 84466 | <1% | 48 | $457.22 | |
| 80164 | <1% | 55 | $450.60 | |
| 81001 | <1% | 211 | $442.60 | |
| 86140 | <1% | 104 | $399.53 | |
| 85651 | <1% | 84 | $273.08 | |
| 84402 | <1% | 13 | $198.41 | |
| 81003 | <1% | 127 | $184.94 | |
| 83001 | <1% | 12 | $178.40 | |
| 85610 | <1% | 49 | $149.54 | |
| 84460 | <1% | 36 | $113.22 | |
| 84450 | <1% | 36 | $110.71 | |
| 86592 | <1% | 28 | $90.42 | |
| 87077 | <1% | 14 | $63.63 | |
| 83690 | <1% | 13 | $51.30 | |
| 87088 | <1% | 12 | $51.00 | |
| 84479 | <1% | 162 | $26.75 | |
| 83550 | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBRATTON, ANDREA (BILLING MANAGER)